Search

everythinglearnresearchcommunity

for

Search:↓

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

Wearing headcovers doesn't affect male-pattern hair loss severity.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.

Microneedling combined with minoxidil is more effective and safe for hair growth in men with hair loss.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Latanoprost 0.1% may effectively treat hair loss.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.

Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.

A new hair loss treatment is being developed using reprogrammed stem cells to grow new hair follicles.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Alopecia negatively affects quality of life and mental health.

Health workers in non-COVID wards had higher depression and anxiety rates.

New scale reliably assesses male hair loss with female pattern.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

People with vitiligo or alopecia areata have higher anxiety and depression than healthy people.

Alopecia Areata is linked to higher depression levels.